Market Overview

Polycystic Ovary Syndrome | A Pipeline Analysis Report 2018 | Technavio

Share:

Technavio has announced their latest pipeline analysis report on the polycystic
ovary syndrome market
. The report includes a detailed analysis
of the pipeline molecules under investigation within the defined data
collection period to treat polycystic ovary syndrome.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180720005415/en/

Technavio has published a new report on the drug development pipeline for polycystic ovary syndrome, ...

Technavio has published a new report on the drug development pipeline for polycystic ovary syndrome, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio presents a detailed analysis of the market,
including regulatory framework, drug development strategies, recruitment
strategies, and key companies that are expected to play an essential
role in the growth of the market in the future.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Polycystic ovary syndrome: Market overview

Polycystic ovary syndrome (PCOS) is a hormonal condition, which occurs
when a woman's ovaries or adrenal glands produce more male hormones than
normal. PCOS is a common heterogeneous endocrine disorder characterized
by irregular menses, hyperandrogenism, and polycystic ovaries. It
develops cysts (fluid filled sacs) on the ovaries. It is also known as
Stein-Leventhal syndrome. It is one of the most common hormonal
endocrine disorders. PCOS is linked to the development of other medical
conditions such as insulin resistance, type 2 diabetes, high
cholesterol, high blood pressure, and heart disease.

According to a senior market research analyst at Technavio, "Polycystic
ovary syndrome is the most common cause of female infertility, affecting
6% to 12% of the US women of reproductive age. PCOS is a lifelong health
condition that continues far beyond the child-bearing years."

Polycystic ovary syndrome: Segmentation analysis

This pipeline analysis report segments the polycystic ovary syndrome
market based on therapies employed (monotherapy, combination therapy,
and monotherapy/combination therapy), RoA (oral), therapeutic modality
(small molecule, and biological), targets (kisspeptin receptor, AMPK,
neurokinin 3 receptor, and others), MoA (kisspeptin receptor antagonist,
neurokinin 3 receptor antagonist, AMPK activator, and others ),
geographical segmentation (US, Germany, and Belgium) and recruitment
status (recruiting, active, not recruiting, and completed). It provides
an in-depth analysis of the prominent factors influencing the market,
including drivers, opportunities, trends, and industry-specific
challenges.

Almost 89% of the molecules that are being investigated for the
treatment of polycystic ovary syndrome are small molecule.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

View Comments and Join the Discussion!